Buchang Pharma to invest 100 million yuan in Zhejiang Longpan healthcare fund

财中社··CN·Read original
2▲0 ▼0Impact / 5
Summary · why it matters

Buchang Pharma announced on September 29 that it has signed a partnership agreement with Tibet Ruihan Enterprise Management Consulting Center, a limited partnership, and other partners to subscribe 100 million yuan as a limited partner in Zhejiang Longpan Health and Medical Equity Investment Fund Partnership, a limited partnership. The fund has a total size of 1.95 billion yuan, with Buchang Pharma holding a 5.13 percent stake. In the first half of 2026, Buchang Pharma posted revenue of 5.003 billion yuan and net profit attributable to the parent of 503 million yuan.

Impact on assets 1

Others▲ · 1 stocks

Off-coverage companies 1

Tibet Ruihan Enterprise Management Consulting Center (LP)Private± Mixed
Capitalrelevance

Tibet Ruihan is named as a partner signing the fund agreement, with no specific terms disclosed.

© 2026 MarketIVNews